Document Detail

Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study.
MedLine Citation:
PMID:  23064018     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Anemia is a common and serious complication in patients with inflammatory bowel disease. The present study was dedicated to evaluate the therapeutic efficacy of erythropoietin (EPO) combined with enteral nutrition (EN) in anemic Crohn's disease (CD) patients, in terms of hemoglobin level, treatment success rate, adverse events, and predictor of this therapy.
MATERIALS AND METHODS: We performed a prospective study in CD patients. On the basis of hemoglobin level, all enrolled patients were divided into anemic and nonanemic groups. The anemic group was further divided into EPO and non-EPO subgroups, depending on whether EPO was prescribed. Hematological and other parameters were measured initially and in the first 4 weeks after starting treatment.
RESULTS: In total, 109 patients (49 nonanemic and 60 anemic, including 38 EPO and 22 non-EPO) were included. The prevalence of anemia in CD was 55.05%. Age, disease behavior, Crohn's Disease Activity Index scores, C-reactive protein, and erythrocyte sedimentation rate were significantly different between anemic and nonanemic groups. An increase in hemoglobin level and a significant decrease in C-reactive protein level were observed in the EPO treatment group. Treatment success rate was 63.16% in the EPO group, whereas none of patients achieved treatment success in the non-EPO group.
CONCLUSION: EPO combined with EN can improve the hemoglobin level in anemic CD patients.
Song Liu; Jianan Ren; Zhiwu Hong; Dongsheng Yan; Guosheng Gu; Gang Han; Gefei Wang; Huajian Ren; Jun Chen; Jieshou Li
Related Documents :
23963878 - Effectiveness and safety of rabbit anti-thymocyte globulin in japanese patients with ap...
24206968 - Exclusive low-molecular-weight heparin as bridging anticoagulant after mechanical valve...
24484948 - The usefulness of evaluation of: ferritin, ultrasensitive crp and tissue specific polyp...
22943068 - Cost-effectiveness of early initiation of first-line combination antiretroviral therapy...
23804678 - Is the ross procedure a suitable choice for aortic valve replacement in children with r...
10208708 - Chronic critical limb ischemia: diagnosis, treatment and prognosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-10-12
Journal Detail:
Title:  Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition     Volume:  28     ISSN:  1941-2452     ISO Abbreviation:  Nutr Clin Pract     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-15     Completed Date:  2013-06-28     Revised Date:  2013-09-25    
Medline Journal Info:
Nlm Unique ID:  8606733     Medline TA:  Nutr Clin Pract     Country:  United States    
Other Details:
Languages:  eng     Pagination:  120-7     Citation Subset:  IM; N    
Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / complications,  drug therapy,  therapy*
Biological Markers
C-Reactive Protein / analysis
Crohn Disease / complications,  drug therapy,  therapy*
Dose-Response Relationship, Drug
Enteral Nutrition / methods*
Erythropoietin / therapeutic use*
Logistic Models
Prospective Studies
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Biological Markers; 11096-26-7/Erythropoietin; 9007-41-4/C-Reactive Protein
Comment In:
Nutr Clin Pract. 2013 Aug;28(4):522   [PMID:  23917438 ]
Nutr Clin Pract. 2013 Aug;28(4):523   [PMID:  23736687 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Donor ABCB1 variant associates with increased risk for kidney allograft failure.
Next Document:  Feeding Tube Placement: Errors and Complications.